$0.11
$0.00 (0.00%)
End-of-day quote: 05/04/2024
ASX:PYC
PYC Therapeutics Annual Report
| Year | Year | 2023 | 2014 | 2013 | 2012 | 2011 | 2010 | ||
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$15.81M | $0.74M | $0.71M | $1.92M | $2.36M | $0.60M | |
| GM % | Gross Margin % |
|
100.00% | 0.00% | 0.00% | -58.58% | -28.84% | 0.00% | |
| OM | Operating Margin |
|
-148.24% | 0.00% | 0.00% | -211.95% | -157.63% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.01 | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | -0.00% | -0.00% | 0 | |
| Sha. | Shares |
|
3416.5m | 1002.07m | 466.89m | 466.89m | 405.2m | 235.75m | |
| OCF | Operating Cash Flow |
|
$-24.42M | $-3.20M | $-2.32M | $-4.15M | $-2.94M | $-3.63M | |
| FCF | Free Cash Flow |
|
$-24.91M | $-3.40M | $-2.58M | $-4.50M | $-3.13M | $-3.79M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.01 | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
